Abstract Background Contrasting to the well documented tyrosine kinase inhibitor (TKI)-induced hypertension. little is known on their intrinsic vasomotor effects. We investigated the vasomotor effects of sorafenib. a widely used multikinase inhibitor in the treatment of hepatocellular and renal cell carcinoma and tested the hypothesis that sildenafil. https://www.lorenametaute.com/